European Journal of Cancer
Volume 41, Issue 18 , Pages 2828-2835 , December 2005

Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma

  • Laura Boldrini

      Affiliations

    • Department of Surgery, University of Pisa, 56100 Pisa, Italy
    • ,
  • Silvia Gisfredi

      Affiliations

    • Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, 56100 Pisa, Italy
    • ,
  • Silvia Ursino

      Affiliations

    • Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, 56100 Pisa, Italy
    • ,
  • Pinuccia Faviana

      Affiliations

    • Department of Surgery, University of Pisa, 56100 Pisa, Italy
    • ,
  • Marco Lucchi

      Affiliations

    • Department of Cardio-Thoracic Surgery, University of Pisa, 56100 Pisa, Italy
    • ,
  • Franca Melfi

      Affiliations

    • Department of Cardio-Thoracic Surgery, University of Pisa, 56100 Pisa, Italy
    • ,
  • Alfredo Mussi

      Affiliations

    • Department of Cardio-Thoracic Surgery, University of Pisa, 56100 Pisa, Italy
    • ,
  • Fulvio Basolo

      Affiliations

    • Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, 56100 Pisa, Italy
    • ,
  • Gabriella Fontanini

      Affiliations

    • Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, 56100 Pisa, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 050 992983; fax: +39 050 992942.

Received 19 April 2005 ,Revised 28 July 2005 ,Accepted 25 August 2005.

References 

  1. Fagan KA, Mc Murtry IF, Rodman DM. Role of endothelin-1 in lung disease. Respir Res. 2001;2:90–101
  2. Arinami T, Ishikawa M, Inoue A, et al. Chromosomal assignments of the human endothelin family genes: the endothelin 1 gene (EDN1) to 6p23 p24, the endothelin 2 gene (EDN2) to 1p34, and the endothelin 3 gene (EDN3) to 20q13.2 q13.3. Am J Hum Genet. 1991;48:990–996
  3. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325–415
  4. Ahmed SI, Thompson J, Coulson JM, et al. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol. 2000;22:422–431
  5. Levin ER. Endothelins. N Engl J Med. 1995;333:356–363
  6. Salani D, Di Castro V, Nicotra MR, et al. Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol. 2000;157:1537–1547
  7. Asham E, Shankar A, Loizidou M, et al. Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET (A) receptor antagonism. Br J Cancer. 2001;85:1759–1763
  8. Nelson JB, Chan-Tack K, Hedican SP, et al. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res. 1996;56:663–668
  9. Wulfing P, Diallo R, Kersting C, et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin Cancer Res. 2003;9:4125–4131
  10. Bagnato A, Tecce R, Di Castro V, et al. Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells. Cancer Res. 1997;57:1306–1311
  11. Pedram A, Rasandi M, Hu R-M, et al. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem. 1997;272:17097–17103
  12. Rosano L, Varmi M, Salani D, et al. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res. 2001;61:8340–8346
  13. Salani D, Taraboletti G, Rosano L, et al. Endothelin-1 induced an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol. 2000;157:1703–1711
  14. Cruz A, Parnot C, Ribatti D, et al. Endothelin-1, a regulator of angiogenesis in the chick chorioallantoic membrane. J Vasc Res. 2001;38:536–545
  15. Sakamoto A, Yanagisawa M, Sakurai T, et al. Cloning and functional expression of human cDNA for the ETB endothelin receptor. Biochem Biophys Res Commun. 1991;178:656–663
  16. Morbidelli L, Orlando C, Maggi CA, et al. Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am J Physiol. 1995;269:4686–4695
  17. Wren AD, Hiley CR, Fan TD. Endothelin-3 mediated proliferation in wounded human umbilical vein endothelial cells. Biochem Biophys Res Commun. 1993;196:369–375
  18. Noiri E, Hu Y, Bahou WF, et al. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J Biol Chem. 1997;272:1747–1752
  19. Goligorsky MS, Budzikowski AS, Tsukahara H, et al. Co-operation between endothelin and nitric oxide in promoting endothelial cells migration and angiogenesis. Clin Exp Pharmacol Physiol. 1999;26:269–271
  20. Alberts GF, Peifley KA, Johns A, et al. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem. 1994;269:10112–10118
  21. Bagnato A, Catt KJ. Endothelins as autocrine regulators of tumors cell growth. Trends Endocrinol Metab. 1998;9:378–383
  22. Wulfing P, Kersting C, Tio J, et al. Endothelin-1, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor and angiogenesis in breast cancer. Clin Cancer Res. 2004;10:2393–2400
  23. Shankar A, Loizidou M, Aliev G, et al. Raised endothelin 1 levels in patients with colorectal liver metastases. Br J Surg. 1998;85:502–506
  24. Stiles JD, Ostrow PT, Balos LL, et al. Correlation of endothelin-1 and transforming growth factor β1 with malignancy and vascularity in human gliomas. J Neuropathol Exp Neurol. 1997;56:435–439
  25. Kojima K, Nihei Z. Expression of endothelin-1 immunoreactivity in breast cancer. Surg Oncol. 1995;4:309–315
  26. Yamashita J, Ogawa M, Sakai K. Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer. Surgery. 1995;117:601–608
  27. World Health Organization . The World Health Organization histologic typing of lung tumors. Am J Clin Pathol. 1982;77:123–136
  28. American Joint Committee on Cancer . Manual for staging of Cancer. 4th ed.. Philadelphia: JB Lippincott; 1992;p. 115–122
  29. Fontanini G, Boldrini L, Chine S, et al. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas. Br J Cancer. 1999;79:363–369
  30. Boldrini L, Calcinai A, Silvestri V, et al. Quantitation by competitive PCR assay of vascular endothelial growth factor in non-small cell lung carcinomas. Int J Oncol. 1999;14:161–168
  31. Yamashita J, Ogawa M, Egami H, et al. Abundant expression of immunoreactive endothelin 1 in mammary phyllodes tumor: possible paracrine role of endothelin 1 in the growth of stromal cells in phyllodes tumor. Cancer Res. 1992;52:4046–4049
  32. Bagnato A, Tecce R, Moretti C, et al. Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells. Clin Cancer Res. 1995;1:1059–1066
  33. Battistini B, Chailler P, D’Orleans-Juste P, et al. Growth regulatory properties of endothelins. Peptides. 1993;14:385–399
  34. Sullivan ME, Mumtaz FH, Khan MA, et al. Endothelins in the urinary tract. BJU Intern. 2000;86:97–106
  35. Bagnato A, Natali PG. Endothelin receptors as novel targets in tumor therapy. J Transl Med. 2004;2:1–9
  36. Yang X, Liu L, Qi H. Study on endothelin-1 positive expression and quantitative analysis in lung cancer. Zhonghua Jie He He Hu Xi Za Zhi. 1998;21:111–113
  37. Arun C, DeCatris M, Hemingway DM, et al. Endothelin-1 is a novel prognostic factor in non-small cell lung cancer. Int J Biol Markers. 2004;19:262–267
  38. Carpagnano GE, Foschino-Barbaro MP, Resta O, et al. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer. Oncology. 2004;66:180–184
  39. Drimal J, Drimal J, Drimal D. Enhanced endothelin ETB receptors down-regulation in human tumor cells. Eur J Pharmacol. 2000;396:19–22
  40. Sullivan ME, Mumtaz FH, Khan MA, et al. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res. 1999;59:720–727
  41. Pagotto U, Arzberger T, Hopfner U, et al. Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth. J Clin Investig. 1995;96:2017–2025
  42. Wu-Wong JR, Chiou W, Magnuson SR, et al. Human astrocytoma U138 MG cells express predominantly type-A endothelin receptor. Biochim Biophys Acta. 1996;1311:155–163
  43. Nelson JB, Hedican SP, George DJ, et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med. 1995;1:944–949
  44. Nelson JB, Lee WH, Nguyen SH, et al. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res. 1997;57:35–37
  45. Yamashita J, Ogawa M, Inada K, et al. A large amount of endothelin-1 is present in human breast cancer tissues. Res Commun Chem Pathol Pharmacol. 1991;74:363–369
  46. Alanen K, Deng DX, Chakrabarti S. Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma. Histopathology. 2000;36:161–167

PII: S0959-8049(05)00800-2

doi: 10.1016/j.ejca.2005.08.030

European Journal of Cancer
Volume 41, Issue 18 , Pages 2828-2835 , December 2005

Article Tools

* Image Usage & Resolution